期刊文献+

我院高危药品管理的探索与实践 被引量:32

Exploration and Practice of the Management of High-risk Medicines in Our Hospital
原文传递
导出
摘要 目的:探索提高医院高危药品管理水平的方法。方法:明确我院高危药品管理中存在的问题,制订相应的管理制度和措施,并以管理干预前后对医务人员进行高危药品相关知识调查的结果进行管理效果评价。结果与结论:我院高危药品的管理主要存在如下问题:医务人员不熟悉高危药品的概念和分类,未制订高危药品的目录、管理制度和措施、特殊标识等;针对上述问题分别制订相应措施,包括建立高危药品管理体系、确定最需加强管理的高危药品、建立高危药品管理的信息化网络、提高医务人员风险意识等;调查结果表明多项认知指标在管理干预后与干预前比较有明显改进。结合高危药品的特点和管理中存在的问题,制订切实可行的管理制度和措施,可以明显提高医院高危药品的管理水平,并减少由此引起的严重药物不良事件的发生。 OBJECTIVE:To explore the approach to improve the management of hospital high-risk medicines.METHODS:The problems of the management of high-alert medicines in our hospital were confirmed,appropriate management systems and measures were formulated,and relative knowledge of medical staff on high-risk medicines was investigated before and after intervention to evaluate the effect of management.RESULTS CONCLUSIONS:The main management problems of high-risk medicines in our hospital were as follows:the medical staff are not familiar with its concept and classification;there are no list,management system and measures,special logo and warning station for high-risk medicines,and so on.Relevant measures were developed to solve the above-mentioned problems,including establishing high-risk medicines management system,defining high-risk medicines which mostly needed to strengthen management,formulating high-risk medicines management information network,improving consciousness of risk protection of medical staff.Multiple cognition index were improved significantly after intervention.Based on the characteristics of high-risk medicines and the management of problems,the management system and measures are formulated to improve the management of high-risk medicines and decrease the occurrence of drug adverse event of it.
出处 《中国药房》 CAS CSCD 2012年第45期4259-4262,共4页 China Pharmacy
关键词 高危药品 管理 问题 措施 High-risk medicines Management Problems Measures
  • 相关文献

参考文献14

  • 1Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. Excess length of stay, ex- tra costs, and attributable mortality[J]. JAMA, 1997, 277 (4) : 301.
  • 2CuUen DJ, Sweitzer B J, Bates DW, et al. Preventable ad- verse drug events in hospitalized patients: a comparative study of intensive care and general care units[J]. Crit Care Med, 1997,25(8) : 1 289.
  • 3Bates DW, Spell N, Cullen D J, et al. The costs of adver- se drug events in hospitalized patients. Adverse Drug Events Prevention Study Group[J]. JAMA, 1997,277 (4) : 307.
  • 4Bates DW, Cullen D J, Laird N, et al. Incidence of adve- rse drug events and potential adverse drug events. Implica- tions for prevention. ADE Prevention Study Group[J]. JA- MA, 1995,274(1) :29.
  • 5Leape LL, Brennan TA, Laird N, et aL The nature of ad- verse events in hospitalized patients. Results of the Har- vard Medical Practice Study II [J]. NEngl J Med, 1991, 324(6) :377.
  • 6Belknap S. ' High-alert' medications and patient safety[J]. lntJQualHealth Care, 2001,13(4) : 339.
  • 7Cohen MR, Kilo CM. High-alert Medications:Safeguard- ing against Errors[M]. Washington, DC: American Phar- maceutical Association, 1999: 5.1-5.40.
  • 8Institute for Safe Medication Practices-ISME ISMP's list of high-alert medication[EB/OL ]. https://www.ismp.org/ Tools/highalertmedications.pdf.2012-05.2012-05-14.
  • 9Paparella S. High-alert medication: shared accountability for risk identification and error prevention[J]. J Emerg Nurs, 2010,36(5) : 476.
  • 10许金美,卜玲珍,姚志芳,朱红.持续质量改进在病区高危药品管理中的应用[J].中医药管理杂志,2011,19(1):81-82. 被引量:26

二级参考文献26

  • 1何超,朱君亚,罗启莱.美国医院质量管理概况与借鉴[J].中华医院管理杂志,2005,21(1):12-13. 被引量:64
  • 2刘喜军,魏水易,吴永佩,颜青.医院药物治疗质量综合评价指标体系研究[J].中国医院药学杂志,2005,25(5):462-463. 被引量:10
  • 3王梅芬,孙亚军.高警讯药物临床使用安全管理概述[J].现代护理(上旬版),2007,13(5):1250-1252. 被引量:21
  • 4Anonymous. Joint Commission IDs five high-alert meds[J]. ED-Manag, 2000,12(2): 21-22.
  • 5Suzanne G, Molly PC, Nicholas EK, et al. Barbara Crawford. Implementation of a High-Alert Medication Program[J]. The Permanente J, 2008, 12(2) : 15-22.
  • 6McKee J, Cleary S. High-Risk, High-Alert Medication Management Practices in a Regional State Psychiatric Facility[J]. Hospital Pharnmcy, 2007, 42(4)I 323-330.
  • 7Laurie B. Hospitals Can Reduce Patient Harm Related to High-Alert Medications [J].Jt Comm J Qual Patient Saf, 2007, 33:537-548.
  • 8'High alert- medications and patient safety[J]. Int J Qual Health Care,2001,13(4):339-340.
  • 9Institute for Safe Medication Practices. ISMP's list of high- alert medications [EB/OL]. [2008-11-12]. http://www. ismp. org/tools/highalertmedications, pdf.
  • 10Golembiewski J, Wheeler P J. High alert medications in the perioperative setting[J]. J Perianesth Nuts, 2007,22(6) :435- 437.

共引文献328

同被引文献184

  • 1郭凤歌.医院高危药品的管理与用药安全[J].中国民康医学,2012,24(22):2798-2798. 被引量:2
  • 2万向平.基层医院药品管理中的常见问题及改进措施[J].求医问药(下半月刊),2012,10(12):487-488. 被引量:5
  • 3左月燃.对加强护理安全管理的认识和思考[J].中华护理杂志,2004,39(3):191-192. 被引量:702
  • 4陈丽芳,彭慕莲,杨建群.病区药品管理中的常见问题及改进措施[J].护理管理杂志,2006,6(11):39-40. 被引量:58
  • 5The Joint Commission. High-alert medications and patient safety[J/OL]. ( 1999-11 ) [2008-11-12].http ://www.j oint- commission.org/entinelevents/sentineleventalert/sea_l 1. htm.
  • 6Anon. High-alert medications and patient safety[J]. Inter- national Journal for Quality in Health Care, 2001, 13 (4):339.
  • 7Institute for Safe Medication Practices. ISMP' s list of high- alert medications[EB/OL]. (2012-03) [2012-04-14]. http //www.ismp.org/Tools/highalert medications.pdf.
  • 8中国药学会医院药学专业委员会用药安全项目组.高危药品分级管理策略及推荐目录『EB/OL].(2012-03)[2012-03-28].http://www.cpahp.org.cn/ccyyf/news/201203/1435html.
  • 9Shlom EA, May SK. Managing high-risk medications: implementing medication management standard[J]. Hosp Pharm, 2006,41 (5) : 470.
  • 10中国药学会医院药学专业委员会用药安全项目组.高危药品分级管理策略及推荐目录[EB/OL].[2012-12-01]http://www.cpahp.org.crgccyyf/news/201203/1435.htm.

引证文献32

二级引证文献206

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部